Callan Family Office’s Manhattan Associates MANH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.92M Buy
20,960
+2,839
+16% +$391K 0.06% 297
2026
Q1
$2.41M Buy
18,121
+2,842
+19% +$426K 0.05% 306
2025
Q4
$2.65M Buy
15,279
+414
+3% +$75.7K 0.06% 293
2025
Q3
$3.05M Sell
14,865
-819
-5% -$173K 0.1% 215
2025
Q2
$3.1M Buy
15,684
+14,448
+1,169% +$2.62M 0.1% 216
2025
Q1
$214K Sell
1,236
-1,081
-47% -$225K 0.02% 512
2024
Q4
$626K Buy
+2,317
New +$660K 0.04% 326

Other funds holding MANH

Callan Family Office's MANH Position: Q2 2026 in Review

Callan Family Office increased its Manhattan Associates (MANH) stake by 16% in Q2 2026, buying an estimated $391K and bringing the position to 20,960 shares worth $2.92M. The position accounts for 0.06% of the portfolio, ranked #297.

Callan Family Office first reported a position in MANH in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.1M in Q2 2025. 507 funds tracked by Wall St. Rank hold MANH as of Q2 2026.

  • Callan Family Office held 20,960 shares of Manhattan Associates worth $2.92M as of Q2 2026.
  • Callan Family Office bought 2,839 Manhattan Associates shares in Q2 2026, an estimated $391K.
  • Manhattan Associates made up 0.06% of Callan Family Office's portfolio in Q2 2026, its #297 holding.
  • Callan Family Office first reported a position in Manhattan Associates in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Manhattan Associates position peaked at $3.1M in Q2 2025.
  • 507 funds tracked by Wall St. Rank held Manhattan Associates as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.